Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States.

Enos, Clinton W; O'Connell, Katie A; Harrison, Ryan W; McLean, Robert R; Dube, Blessing; Van Voorhees, Abby S

Enos, Clinton W; O'Connell, Katie A; Harrison, Ryan W; McLean, Robert R; Dube, Blessing; Van Voorhees, Abby S.

Afiliación

Enos CW; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia, USA.
O'Connell KA; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Harrison RW; CorEvitas, LLC, Waltham, Massachusetts, USA.
McLean RR; CorEvitas, LLC, Waltham, Massachusetts, USA.
Dube B; CorEvitas, LLC, Waltham, Massachusetts, USA.
Van Voorhees AS; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia, USA.

JID Innov ; 1(2): 100025, 2021 Jun.

Article en En | MEDLINE | ID: mdl-34909720

Palabras clave

BMI, body mass index; BSA, body surface area; CI, confidence interval; E South Cent, East South Central; IGA, Investigator's Global Assessment; IL-12/23i, IL-12âIL-23 inhibitor; IL-17i, IL-17 inhibitor; IL-23i, IL-23 inhibitor; PASI 75, 75% improvement in PASI; TNFi, TNF inhibitor; US, United States; W South Cent, West South Central

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: JID Innov Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google